PRVA insider transaction filings
Privia Health Group, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen PRVA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 7 filings by 2 insiders — 463,384 shares, $12,194,592 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 88,110 shares @ $25.33 ($2,231,826) by Morris Matthew Shawn, filed 2026-06-30.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Morris Matthew Shawn — Director | 3 | — | 7 legs · 399,579 sh · $10,476,190 | 12 |
| Mountcastle David — EVP & Chief Financial Officer | 4 | — | 4 legs · 63,805 sh · $1,718,402 | 5 |
| Ernest Opella Finley — Director | 1 | — | — | 1 |
Recent Form 4 filings — Privia Health Group, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Ernest Opella Finley — Director | Grant/award (A): 6,350 @ $0 | EDGAR |
| 2026-07-13 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 21,275 @ $27.67 | EDGAR |
| 2026-07-09 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 600 @ $27.57 | EDGAR |
| 2026-07-07 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 24,734 @ $27.50 | EDGAR |
| 2026-07-07 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 59,037 @ $2 · Sale (S): 59,037 @ $27.33 · Option exercise (M): 53,722 @ $2 · Sale (S): 53,722 @ $27.24 · Option exercise (M): 59,037 (derivative) @ $0 · Option exercise (M): 53,722 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 52,823 @ $2 · Sale (S): 52,823 @ $25.72 · Option exercise (M): 82,675 @ $2 · Sale (S): 45,634 @ $26.52 · Sale (S): 37,041 @ $26.93 · Option exercise (M): 52,823 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-30 | 4 | Mountcastle David — EVP & Chief Financial Officer | Option exercise (M): 17,196 @ $2 · Sale (S): 17,196 @ $25.18 · Option exercise (M): 5,962 (derivative) @ $0 · Option exercise (M): 1,001 (derivative) @ $0 · Option exercise (M): 1,336 (derivative) @ $0 · Option exercise (M): 8,897 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 88,110 @ $2 · Sale (S): 88,110 @ $25.33 · Option exercise (M): 63,212 @ $2 · Sale (S): 63,212 @ $25.33 · Option exercise (M): 88,110 (derivative) @ $0 · Option exercise (M): 63,212 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Ryu Jaewon — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | Kimmet Pamela O — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | McCarthy Thomas A — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | Morris Matthew Shawn — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | KING DAVID P — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | SOISTMAN FRANCIS S JR — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | COCOZZA NANCY G — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-22 | 4 | BERBERIAN LANCE — Director | Grant/award (A): 8,463 @ $0 | EDGAR |
| 2026-05-13 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 3,385 @ $22.60 | EDGAR |
| 2026-05-13 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 105,439 @ $22.55 · Sale (S): 15,647 @ $22.64 | EDGAR |
| 2026-05-05 | 4 | Mountcastle David — EVP & Chief Financial Officer | Option exercise (M): 7,179 @ $2 · Sale (S): 7,179 @ $25.03 · Option exercise (M): 1,206 @ $2 · Sale (S): 1,206 @ $25 · Option exercise (M): 1,297 (derivative) @ $0 · Option exercise (M): 541 (derivative) @ $0 · +6 more | EDGAR |
| 2026-05-05 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 17,096 @ $2 · Sale (S): 17,096 @ $24.99 · Option exercise (M): 1,017 @ $2 · Sale (S): 1,017 @ $24.96 · Option exercise (M): 17,096 (derivative) @ $0 · Option exercise (M): 1,017 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 5,566 @ $20.85 | EDGAR |
| 2026-03-18 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 26,509 @ $22.11 | EDGAR |
| 2026-03-18 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 6,391 @ $22.11 | EDGAR |
| 2026-03-16 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 26,763 @ $21.90 · Sale (S): 27,229 @ $21.52 | EDGAR |
| 2026-03-16 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 6,453 @ $21.90 · Sale (S): 6,565 @ $21.52 | EDGAR |
| 2026-03-12 | 4 | Fargis Edward C — EVP & General Counsel | Grant/award (A): 28,268 @ $0 | EDGAR |
| 2026-03-12 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 21,097 @ $22.71 · Grant/award (A): 141,342 @ $0 · Grant/award (A): 171,904 @ $0 | EDGAR |
| 2026-03-12 | 4 | Mountcastle David — EVP & Chief Financial Officer | Grant/award (A): 35,335 @ $0 · Grant/award (A): 42,584 @ $0 | EDGAR |
| 2026-03-10 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 21,440 @ $23.15 · Sale (S): 21,915 @ $22.84 · Sale (S): 1,219 @ $23.37 · Sale (S): 18,865 @ $22.84 | EDGAR |
| 2026-03-10 | 4 | Fargis Edward C — EVP & General Counsel | Sale (S): 4,394 @ $23.15 · Sale (S): 4,949 @ $22.84 | EDGAR |
| 2026-03-10 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 5,177 @ $23.15 · Sale (S): 5,829 @ $22.84 | EDGAR |
| 2026-03-02 | 4 | Mountcastle David — EVP & Chief Financial Officer | Option exercise (M): 5,361 @ $2 · Sale (S): 5,361 @ $25 · Option exercise (M): 7,697 @ $2 · Sale (S): 7,697 @ $25.05 · Option exercise (M): 1,668 (derivative) @ $0 · Option exercise (M): 1,100 (derivative) @ $0 · +6 more | EDGAR |
| 2026-03-02 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 7,788 @ $2 · Sale (S): 7,788 @ $24.99 · Option exercise (M): 16,550 @ $2 · Sale (S): 16,550 @ $25 · Option exercise (M): 7,788 (derivative) @ $0 · Option exercise (M): 16,550 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Mountcastle David — EVP & Chief Financial Officer | Option exercise (M): 23,887 @ $2 · Sale (S): 23,887 @ $25.03 · Option exercise (M): 7,698 (derivative) @ $0 · Option exercise (M): 4,792 (derivative) @ $0 · Option exercise (M): 3,430 (derivative) @ $0 · Option exercise (M): 7,967 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Morris Matthew Shawn — Director | Option exercise (M): 13,647 @ $2 · Sale (S): 13,647 @ $25.01 · Option exercise (M): 13,647 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | BERBERIAN LANCE — Director | Grant/award (A): 7,668 @ $0 | EDGAR |
| 2025-05-23 | 4 | Maryland Patricia Anne — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | Ryu Jaewon — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | Kimmet Pamela O — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | McCarthy Thomas A — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | Morris Matthew Shawn — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | KING DAVID P — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | WICHMANN DAVID S — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-23 | 4 | COCOZZA NANCY G — Director | Grant/award (A): 8,396 @ $0 | EDGAR |
| 2025-05-14 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 13,773 @ $24.99 · Sale (S): 15,909 @ $24.52 | EDGAR |
| 2025-05-14 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 3,322 @ $24.99 | EDGAR |
| 2025-05-02 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 3,445 @ $23.33 | EDGAR |
| 2025-05-02 | 4 | Mehrotra Parth — Chief Executive Officer, Director | Sale (S): 15,100 @ $23.33 · Sale (S): 17,365 @ $23.08 | EDGAR |
| 2025-05-02 | 4 | Morris Matthew Shawn — Director | Sale (S): 10,309 @ $23.33 | EDGAR |
| 2025-04-03 | 4 | Mountcastle David — EVP & Chief Financial Officer | Sale (S): 5,630 @ $22.38 | EDGAR |
Recent 8-K events — Privia Health Group, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-23 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PRVA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →